Granules India is currently trading at Rs. 367.10, up by 2.40 points or 0.66% from its previous closing of Rs. 364.70 on the BSE.
The scrip opened at Rs. 373.70 and has touched a high and low of Rs. 383.80 and Rs. 358.30 respectively. So far 374337 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 438.00 on 01-Dec-2020 and a 52 week low of Rs. 271.05 on 31-Jul-2020.
Last one week high and low of the scrip stood at Rs. 387.40 and Rs. 358.30 respectively. The current market cap of the company is Rs. 9000.50 crore.
The promoters holding in the company stood at 42.04%, while Institutions and Non-Institutions held 21.21% and 36.76% respectively.
Granules India has reported results for first quarter ended June 30, 2021.
The company has reported a fall of 28.12% in its net profit at Rs 89.85 crore for the quarter under review as compared to Rs 125.00 crore for the same quarter in the previous year. Total income of the company decreased by 1.30% at Rs 739.47 crore for Q1FY22 as compared Rs 749.23 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 7.85% in its net profit at Rs 120.20 crore for the quarter under review as compared to Rs 111.45 crore for the same quarter in the previous year. Total income of the company increased by 15.68% at Rs 857.47 crore for Q1FY22 as compared Rs 741.23 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1854.15 |
Dr. Reddys Lab | 1350.75 |
Cipla | 1497.80 |
Lupin | 2357.65 |
Zydus Lifesciences | 1001.20 |
View more.. |